GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: StockDung	3/22/2011 12:21:29 PM
	of 5582

Investor Suit over Disclosure of Zicam Side Effects Gets Green Light by Supreme Court Posted Mar 22, 2011 10:21 AM CDT By Debra Cassens Weiss The U.S. Supreme Court is allowing an investor lawsuit that claims the makers of Zicam should have disclosed reports that the cold remedy caused a loss of smell, even though the reported incidents weren’t statistically significant. Justice Sonia Sotomayor wrote the opinion (PDF) for a unanimous court. The manufacturer, Matrixx Initiatives Inc., had argued there was no material misrepresentation supporting a suit under federal securities laws. “We conclude that the materiality of adverse event reports cannot be reduced to a bright-line rule,” Sotomayor wrote. The decision affirms a ruling by the San Francisco-based 9th U.S. Circuit Court of Appeals. The case is Matrixx Initiatives v. Siracusano.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next